Related Experiment Video
Updated: May 14, 2026

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
Published on: September 27, 2024
Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas
Jason Chouake1, David Schairer, Allison Kutner
1Department of Medicine, Division of Dermatology, Montefiore Medical Center, Bronx, NY, USA.
Abstract:
Pseudomonas aeruginosa is a community-acquired, nosocomial pathogen that is an important cause of human morbidity and mortality; it is intrinsically resistant to several antibiotics and is capable of developing resistance to newly developed drugs via a variety of mechanisms. P aeruginosa's ubiquity and multidrug resistance (MDR) warrants the development of innovative methods that overcome its ability to develop resistance. We have previously described a nitric oxide-releasing nanoparticle (NO-np) platform that effectively kills gram-positive and gram-negative organisms in vitro and accelerates clinical recovery in vivo in murine wound and abscess infection models. We have also demonstrated that when glutathione (GSH) is added to NO-np, the nitroso intermediate S-nitrosoglutathione (GSNO) is formed, which has greater activity against P aeruginosa and other gram-negative organisms compared with NO-np alone. In the current study, we evaluate the potential of NO-np to generate GSNO both in vitro and in vivo in a murine excisional wound model infected with an MDR clinical isolate of P aeruginosa. Whereas NO-np alone inhibited P aeruginosa growth in vitro for up to 8 hours, NO-np+GSH completely inhibited P aeruginosa growth for 24 hours. Percent survival in the NO-np+GSH-treated isolates was significantly lower than in the NO-np (36.1% vs 8.3%; P=.004). In addition, NO-np+GSH accelerated wound closure in P aeruginosa-infected wounds, and NO-np+GSH-treated wounds had significantly lower bacterial burden when compared to NO-np-treated wounds (P<.001). We conclude that GSNO is easily generated from our NO-np platform and has the potential to be used as an antimicrobial agent against MDR organisms such as P aeruginosa.
Insights
This study shows that combining nitric oxide-releasing nanoparticles (NO-np) with glutathione (GSH) effectively inhibits multidrug-resistant Pseudomonas aeruginosa. This NO-np+GSH approach offers a promising strategy against difficult-to-treat bacterial infections.
Area of Science:
- Antimicrobial research
- Nanotechnology in medicine
- Infectious disease treatment
Background:
- Pseudomonas aeruginosa is a significant cause of hospital-acquired infections, known for its intrinsic and acquired multidrug resistance (MDR).
- Existing antibiotics are becoming less effective against P. aeruginosa, necessitating novel therapeutic strategies.
- Nitric oxide-releasing nanoparticles (NO-np) have shown antimicrobial activity, but their efficacy against MDR strains requires enhancement.
Purpose of the Study:
- To evaluate the efficacy of NO-np in generating S-nitrosoglutathione (GSNO) in vitro and in vivo.
- To assess the antimicrobial potential of NO-np combined with glutathione (GSH) against a multidrug-resistant clinical isolate of P. aeruginosa.
- To investigate the therapeutic effects of NO-np+GSH in a murine wound infection model.
Main Methods:
- In vitro experiments comparing NO-np alone versus NO-np+GSH for P. aeruginosa growth inhibition.
- In vivo study using a murine excisional wound model infected with MDR P. aeruginosa.
- Assessment of bacterial burden, wound closure, and survival rates in treated versus untreated groups.
Main Results:
- NO-np+GSH demonstrated complete inhibition of P. aeruginosa growth in vitro for 24 hours, compared to 8 hours for NO-np alone.
- In vivo, NO-np+GSH treatment significantly reduced bacterial burden and accelerated wound healing in infected mice.
- Survival rates were significantly higher in the NO-np+GSH treated group (36.1%) compared to the NO-np treated group (8.3%).
Conclusions:
- GSNO can be readily generated from the NO-np platform by adding GSH.
- The NO-np+GSH combination exhibits potent antimicrobial activity against MDR P. aeruginosa.
- This platform holds promise as a novel therapeutic agent for combating infections caused by multidrug-resistant pathogens.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Hand hygiene
Hand washing...
Microbial Corrosion
